ilmscore | Wockhardt Limited Predictions
Woc

Wockhardt Limited

Topic
N/A
Accuracy

Recent Predictions

Total: 4
Correct: 0
Incorrect: 0
Pending: 4
Prediction
Author
Predicted at
Status
Video
Wockhardt management aims to build a global organization to maintain leadership in antibiotic drug discovery in the next decade (by 2035).
"So we are now in a process of building a global organization to take the leadership in the next deca..."
Groww Groww
Jan 11, 2026
Pending
3 stocks with busine...
Wockhardt plans to launch its 'Genic Drugs' in India in the second half of FY26 (by March 2026) and globally in FY27 (April 2026 - March 2027).
"Genic Drugs plans to launch India in the second half and global in FY27."
Groww Groww
Jan 11, 2026
Pending
3 stocks with busine...
Wockhardt aims for 20-25% growth in its biotech and diabetes biosimilar segments by doubling capacity within the next 3 years (by January 2029).
"In the biotech and diabetes biosimilar segments, the company is targeting 20 to 25% growth by doubli..."
Groww Groww
Jan 11, 2026
Pending
3 stocks with busine...
Wockhardt, as one of only three players, is poised to benefit from new human insulin market opportunities in India (worth Rs 450 crore) and emerging markets (worth $157 million), following the phase-out of Novo Nordisk's 'Novo Nodex'.
"The phase-out of Novo Nodex has opened up opportunities worth $450 crore in India and $157 million i..."
Groww Groww
Jan 11, 2026
Pending
3 stocks with busine...